— Why it moved
Why RDHL Stock Spiked and Faded Today — August 31, 2026
Redhill Biopharma scored an eighteen million dollar cash injection by selling off its Talicia business, but chasing the pre-market gap left traders sitting on a brutal thirty-five percent loss by the bell.
What moved RDHL stock
Redhill Biopharma is a tiny specialty pharma company focused on gastrointestinal diseases. They announced a deal to divest their seventy percent stake in Talicia for eighteen million upfront cash plus potential milestone payments. Selling a commercial asset for immediate liquidity got attention, but burning off revenue stream for balance-sheet relief is rarely a fundamental re-rating.
The mechanics
With a tiny float of 4.2 million shares and a micro-cap valuation under five million, the asset sale primed the pump for heavy volume. The stock traded over 103 million shares against a 30-day average under 34 thousand, triggering a classic low-float momentum trap.
RDHL by the numbers
The alert window
The alert went out at 7:53 AM ET at $1.41 following a massive pre-market gap. Anyone taking that alert had to stomach a harsh 12.8% drop down to $1.23 before the stock clawed back to a peak of $1.60 at 9:41 AM ET. That peak delivered a modest 13.5% gain over 108 minutes, but the stock spent just 14 total minutes above the alert price.
How RDHL's move ended
The morning bounce collapsed fast as exit liquidity took over. RDHL tumbled straight through the session's start to close at $0.9089, down 35.5% from the alert price and wiping out most of the daily range. Cash-strapped micro-caps selling core assets rarely sustain morning spikes.
The tell: Low-float stocks spending under fifteen minutes above an alert price usually leave late chasers holding heavy bags.